BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31798904)

  • 1. Deficiency of C3a receptor attenuates the development of diabetic nephropathy.
    Li XQ; Chang DY; Chen M; Zhao MH
    BMJ Open Diabetes Res Care; 2019; 7(1):e000817. PubMed ID: 31798904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C3a receptor blockade protects podocytes from injury in diabetic nephropathy.
    Morigi M; Perico L; Corna D; Locatelli M; Cassis P; Carminati CE; Bolognini S; Zoja C; Remuzzi G; Benigni A; Buelli S
    JCI Insight; 2020 Mar; 5(5):. PubMed ID: 32161193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
    Zhang Y; Yan X; Zhao T; Xu Q; Peng Q; Hu R; Quan S; Zhou Y; Xing G
    Clin Exp Immunol; 2017 Jul; 189(1):60-70. PubMed ID: 28295247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-β/smad3 and IKBα pathway.
    Li L; Yin Q; Tang X; Bai L; Zhang J; Gou S; Zhu H; Cheng J; Fu P; Liu F
    PLoS One; 2014; 9(11):e113639. PubMed ID: 25422985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complement C3a receptor is critical in defense against Chlamydia psittaci in mouse lung infection and required for antibody and optimal T cell response.
    Dutow P; Fehlhaber B; Bode J; Laudeley R; Rheinheimer C; Glage S; Wetsel RA; Pabst O; Klos A
    J Infect Dis; 2014 Apr; 209(8):1269-78. PubMed ID: 24273177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein inhibits C3a/C3aR-dependent podocyte autophagy in favor of diabetic kidney disease.
    Zhang L; Li W; Gong M; Zhang Z; Xue X; Mao J; Zhang H; Li S; Liu X; Wu F; Shi J; Fu G
    FASEB J; 2022 Jun; 36(6):e22332. PubMed ID: 35503088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.
    Ma J; Wu H; Zhao CY; Panchapakesan U; Pollock C; Chadban SJ
    Int J Clin Exp Pathol; 2014; 7(2):481-95. PubMed ID: 24551269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis.
    Boos L; Campbell IL; Ames R; Wetsel RA; Barnum SR
    J Immunol; 2004 Oct; 173(7):4708-14. PubMed ID: 15383607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Epidermal Growth Factor Receptor Activation Is Associated With Improved Diabetic Nephropathy and Insulin Resistance in Type 2 Diabetes.
    Li Z; Li Y; Overstreet JM; Chung S; Niu A; Fan X; Wang S; Wang Y; Zhang MZ; Harris RC
    Diabetes; 2018 Sep; 67(9):1847-1857. PubMed ID: 29959129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury.
    Lim AK; Ma FY; Nikolic-Paterson DJ; Kitching AR; Thomas MC; Tesch GH
    Diabetologia; 2010 Aug; 53(8):1772-82. PubMed ID: 20422398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway.
    Yang H; Xie T; Li D; Du X; Wang T; Li C; Song X; Xu L; Yi F; Liang X; Gao L; Yang X; Ma C
    Mol Metab; 2019 May; 23():24-36. PubMed ID: 30862474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated human T lymphocytes express a functional C3a receptor.
    Werfel T; Kirchhoff K; Wittmann M; Begemann G; Kapp A; Heidenreich F; Götze O; Zwirner J
    J Immunol; 2000 Dec; 165(11):6599-605. PubMed ID: 11086104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis.
    Sauter RJ; Sauter M; Reis ES; Emschermann FN; Nording H; Ebenhöch S; Kraft P; Münzer P; Mauler M; Rheinlaender J; Madlung J; Edlich F; Schäffer TE; Meuth SG; Duerschmied D; Geisler T; Borst O; Gawaz M; Kleinschnitz C; Lambris JD; Langer HF
    Circulation; 2018 Oct; 138(16):1720-1735. PubMed ID: 29802205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
    Liang G; Song L; Chen Z; Qian Y; Xie J; Zhao L; Lin Q; Zhu G; Tan Y; Li X; Mohammadi M; Huang Z
    Kidney Int; 2018 Jan; 93(1):95-109. PubMed ID: 28750927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective engraftment of C3aR-/- hematopoietic stem progenitor cells shows a novel role of the C3a-C3aR axis in bone marrow homing.
    Wysoczynski M; Reca R; Lee H; Wu W; Ratajczak J; Ratajczak MZ
    Leukemia; 2009 Aug; 23(8):1455-61. PubMed ID: 19357704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17 deficiency aggravates the streptozotocin-induced diabetic nephropathy through the reduction of autophagosome formation in mice.
    Kim KH; Hong GL; Jung DY; Karunasagara S; Jeong WI; Jung JY
    Mol Med; 2021 Mar; 27(1):25. PubMed ID: 33691614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Complement C3a and C3a Receptor Pathway in Kidney Diseases.
    Gao S; Cui Z; Zhao MH
    Front Immunol; 2020; 11():1875. PubMed ID: 32973774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complement anaphylatoxin C3a receptor (C3aR) contributes to the inflammatory response in dextran sulfate sodium (DSS)-induced colitis in mice.
    Wende E; Laudeley R; Bleich A; Bleich E; Wetsel RA; Glage S; Klos A
    PLoS One; 2013; 8(4):e62257. PubMed ID: 23638016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C3a/C3aR axis mediates anti-inflammatory activity and protects against uropathogenic E coli-induced kidney injury in mice.
    Wu KY; Zhang T; Zhao GX; Ma N; Zhao SJ; Wang N; Wang JX; Li ZF; Zhou W; Li K
    Kidney Int; 2019 Sep; 96(3):612-627. PubMed ID: 31133456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Complement C3a Receptor in Stroke.
    Ahmad S; Bhatia K; Kindelin A; Ducruet AF
    Neuromolecular Med; 2019 Dec; 21(4):467-473. PubMed ID: 31102134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.